Home › Funds › Principal Global Investors › BBIO
Principal Global Investors position in BBIO
BRIDGEBIO PHARMA INC · Health Care
Latest position (Q2 2026)1.02M sh
Reported value held$76.30M
Portfolio Weight0.04%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 48.17K | $2.26M | New |
| Q4 2021 | 33.36K | $556.00K | Reduce |
| Q1 2022 | 33.08K | $336.00K | Reduce |
| Q2 2022 | 28.71K | $260.00K | Reduce |
| Q3 2022 | 30.62K | $305.00K | Add |
| Q4 2022 | 33.00K | $251.44K | Add |
| Q1 2023 | 33.47K | $554.95K | Add |
| Q2 2023 | 40.42K | $695.17K | Add |
| Q3 2023 | 745.67K | $19.66M | Add |
| Q4 2023 | 943.48K | $38.09M | Add |
| Q1 2024 | 1.07M | $33.18M | Add |
| Q2 2024 | 1.13M | $28.50M | Add |
| Q3 2024 | 1.15M | $29.15M | Add |
| Q4 2024 | 1.05M | $28.82M | Reduce |
| Q1 2025 | 1.15M | $39.70M | Add |
| Q2 2025 | 1.03M | $44.50M | Reduce |
| Q3 2025 | 1.27M | $65.83M | Add |
| Q4 2025 | 1.31M | $100.53M | Add |
| Q1 2026 | 1.33M | $98.80M | Add |
| Q2 2026 | 1.02M | $76.30M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBIO
- Vanguard Group 16.86M sh · $1.29B · Q4 2025
- Janus Henderson Group 13.18M sh · $978.61M · Q1 2026
- Farallon Capital Management 10.74M sh · $800.14M · Q2 2026
- Viking Global Investors 9.95M sh · $741.02M · Q2 2026
- Two Sigma Investments 4.75M sh · $353.43M · Q2 2026
- D. E. Shaw & Co 3.66M sh · $272.89M · Q2 2026
- Geode Capital Management 3.42M sh · $254.67M · Q2 2026
- Manulife Financial 1.96M sh · $145.66M · Q2 2026
- Charles Schwab Investment Management 1.71M sh · $127.32M · Q2 2026
- Norges Bank Investment Management 1.69M sh · $126.15M · Q2 2026
- Morgan Stanley 1.69M sh · $126.14M · Q2 2026
- Franklin Resources 59.00M sh · $99.39M · Q2 2026